BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16188299)

  • 21. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers.
    Szostek S; Klimek M; Zawilinska B; Rys J; Kope J; Daszkiewic E
    Acta Biochim Pol; 2006; 53(3):603-7. PubMed ID: 17019439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay.
    Giovannelli L; Lama A; Capra G; Giordano V; Aricò P; Ammatuna P
    J Clin Microbiol; 2004 Aug; 42(8):3861-4. PubMed ID: 15297550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
    Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
    J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
    Walts AE; Lechago J; Bose S
    Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus].
    Ergünay K; Misirlioğlu M; Pinar F; Tuncer ZS; Tuncer S; Ustaçelebi S
    Mikrobiyol Bul; 2007 Apr; 41(2):219-26. PubMed ID: 17682708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array.
    de Antonio JC; Fernández-Olmos A; Mercadillo M; Lindemann ML; Mochales FB
    J Virol Methods; 2008 Apr; 149(1):163-6. PubMed ID: 18328575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
    Hesselink AT; Bulkmans NW; Berkhof J; Lorincz AT; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2006 Oct; 44(10):3680-5. PubMed ID: 17021097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of the xMAP technology in detection of high-risk human papillomavirus].
    Liao GD; Zhang XY; Gao YH; Liu B; Liu X; Li LK; Chen F; Bian ML; Chen W; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):603-7. PubMed ID: 18051713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of HPV test on cell sample from the cervix].
    Vintermyr OK; Skar R; Iversen OE; Haugland HK
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):171-3. PubMed ID: 18202727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system.
    Stevens MP; Garland SM; Tabrizi SN
    J Virol Methods; 2008 Feb; 147(2):290-6. PubMed ID: 17996311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy.
    Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
    Gynecol Oncol; 2006 Nov; 103(2):463-6. PubMed ID: 16626791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GP5+/6+ SYBR Green methodology for simultaneous screening and quantification of human papillomavirus.
    de Araujo MR; De Marco L; Santos CF; Rubira-Bullen IR; Ronco G; Pennini I; Vizzini L; Merletti F; Gillio-Tos A
    J Clin Virol; 2009 Jun; 45(2):90-5. PubMed ID: 19447674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of high risk human papillomavirus testing in an inner London colposcopy clinic.
    Perrons C; Brink N; Jalal H; Watts P; Jelley R
    J Med Virol; 2005 Aug; 76(4):576-82. PubMed ID: 15977240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections.
    Baleriola C; Millar D; Melki J; Coulston N; Altman P; Rismanto N; Rawlinson W
    J Clin Virol; 2008 May; 42(1):22-6. PubMed ID: 18262463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.